Evaluation of the Incidence of Choline-PET Detected Nodal Metastases Among Newly Diagnosed Prostate Cancer Patients With Presumed Absence of Nodal and Distant Metastases.
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Detection of Choline-PET detected nodal metastases
At the time of diagnosis of prostate cancer, the investigators intend to utilize Choline-PET scan to gain evidence of nodal metastatic disease with a motive to assess for a potentially higher sensitivity than with the use of conventional imaging methods such as CT or MRI.
Eligible participants will undergo a Choline-PET scan before the initiation of any cancer specific treatments, that is within a time frame of one week from the time of diagnosis
Ajaikumar Basavalingaiah, MD
HealthCare Global- Bangalore Insititute of Oncology
India: Institutional Review Board